All posts by : Adherium

Melbourne, Australia-based smart inhaler company Adherium has been selected to supply the technology for a multi-country research program in Europe that will seek to establish whether home monitoring and mobile.

Meet Adherium at the British Thoracic Society Winter Meeting 2016 7 to 9 December 2016 Location QEII Centre Broad Sanctuary Westminster London SW1P 3EE Exhibiting on stand 18 3rd floor,.

With nearly 40 published peer-reviewed journal articles under its belt, Adherium is hoping that the latest clinical data which underlines the ability of the company’s Smartinhaler to improve outcomes for.

Gabriella Rogers reports on a new combination treatment for asthma sufferers. Click here to watch the story.  

Chief Executive Officer and Co-founder, Garth Sutherland is scheduled to speak at the Australia Biotech Invest 2016 conference being to be held on 26-27 October, 2016 at the Melbourne Convention Centre, in.

Melbourne, Australia, 13 June 2016: Adherium Limited (ASX: ADR), a global leader in digital health technologies that address sub- optimal medication use in chronic disease, today announced that AstraZeneca will.

5,700 Adherium Smartinhaler™ devices plus associated software and communications technologies to be supplied through to 2018 Study in New Zealand, Australia, the United Kingdom & Italy Supply agreement with leading.

August 5, 2015 – Australians and New Zealanders have an opportunity to invest in a highly promising digital health technology company that substantially improves medication adherence and patient health outcomes.